EClinCloud Annual Review | 2023, Witnessed with You; 2024, Into a New Journey!

Source: EClinCloud. Author: EClinCloud.






EClinCloud · 2023
Highlights of the Journey
In the broad evolution of clinical trials, digitalization plays a major driving role. Throughout this year, EClinCloud stayed true to its mission of "bringing effective treatments to patients through technological innovation," moving steadily forward with every milestone clearly in view!

Keyword:
Strengthening Core Capabilities
In 2023, along the path of clinical trial digitalization, EClinCloud remained focused on refining its products and deepening its services.
We increased R&D investment and successively launched 12 systems, including eCOA, CTMS, eTMF, EDC, and RTSM, supporting clinical trials with specialized digital technology;
With continuous iteration and upgrades across features, system performance improved significantly—response time was reduced by 50% and processing capacity increased by 70%, meeting clients' complex operational needs;
At the same time, taking a client-centric approach, we carefully built and delivered a complex functional requirement within just 7 days, earning strong recognition from the client;
Building on this foundation, in 2023 EClinCloud saw new contract volume grow by 172% year-over-year and client count grow by 84% year-over-year, while continuing to add international project experience;
Even more encouragingly, EClinCloud earned widespread recognition through successful case studies—such as supporting a COVID-19 drug in passing CFDI inspection and receiving marketing approval. "Professional, trustworthy, ensuring quality while improving efficiency" has been the consistent feedback from our clients!



Keyword:
Awards and Recognition
Throughout the remarkable chapter of 2023, EClinCloud received repeated recognition.
During the year, EClinCloud successfully held its first User Conference, engaging face-to-face with professionals across related industry sectors to share achievements in the digital transformation and upgrading of clinical research, and receiving genuine praise from major pharmaceutical companies!
Beyond word-of-mouth reputation, we earned tangible awards: in 2023, EClinCloud received 5+ honors in the pharmaceutical and digitalization sectors—representing professional recognition from both the industry and clients—and achieved new breakthroughs with 5+ qualifications and certifications, demonstrating EClinCloud's capabilities in company scale, technological innovation, and software development.
Industry awards received throughout the year include:
2023 Future Healthcare 100 – China Innovative Digital Healthcare Top 100
2023 China Biopharma Frontrunners 100 – Digital Healthcare
2023 Outstanding China Pharmaceutical Digitalization Service Provider
2023 China Pharmaceutical Digitalization Enterprises Top 10
Bronze Award, Yangtze River Delta Jujing Sci-Tech Innovation Competition
Enterprise qualifications and certifications obtained include:
Innovative Small and Medium-sized Enterprise (SME)
Technology-based Small and Medium-sized Enterprise (SME)
Double-Soft Enterprise (Software Enterprise and Software Product)
National High-Tech Enterprise
Specialized, Refined, Differential, and Innovative (SRDI) SME






Keyword:
Innovation and Breakthroughs
Amid the sweeping wave of AI in 2023, EClinCloud also believed that new technologies would enable new approaches, and continued exploring and applying artificial intelligence technologies.
For example, AI-enabled capabilities provide automated detection of blank pages and blurred content in scanned files to improve document processing efficiency, and support document correction to ensure file accuracy and readability.
For document filing, content duplication checks help prevent redundant storage, while automatic filing-folder recommendations based on document content make automated document classification intelligent and convenient.
As another example, using "AI imaging" technology, it intelligently recognizes and automatically intercepts images that do not meet requirements for photo-capture items such as skin and oral cavity images, protecting participant privacy and ensuring clinical trial compliance and data accuracy.

Keyword:
Rooted and United
Through its exploration and growth in 2023, EClinCloud recognized that becoming an industry leader ultimately comes back to corporate culture and its team.
This year, we were not only colleagues at work, but also partners learning together. The "Middle Management Leadership" training became a new classroom for improvement, where everyone studied and discussed together, strengthened professional capabilities, and achieved both individual and team growth.
We also emphasize that our corporate vision is not merely a slogan on the wall, but an inner spark within each of us, always ready to ignite the team's sense of mission and creativity. When it came to team activities, there was truly a wide variety—from afternoon teas to relaxed group outings and the annual company gathering—where everyone exchanged ideas, built rapport, and brought fresh energy to our company culture!









Memories Forged in 2023
Beginning a New Journey in 2024
In the New Year, Soaring High in the Year of the Dragon
EClinCloud will continue to stay innovation-driven
Market-oriented
Customer-centered
Achieving product upgrades
Internationalization and AI enablement
In 2024
Please continue moving forward with us
Striding toward broader horizons!
EClinCloud is a technology company dedicated to clinical R&D. It provides an integrated, interconnected all-in-one clinical trial cloud platform (including eCOA, CTMS, eTMF, EDC, RTSM, RM, and other technology products and solutions, with capabilities such as scale design, scale copyright management, linguistic validation, rater training, and data quality analysis) as well as clinical trial endpoint assessment technologies across therapeutic areas (including central nervous system and ophthalmology). Combining frontier technology with life sciences data, EClinCloud is building a globally leading "patient-centered" SaaS cloud platform supporting clinical evidence to help domestic and international pharmaceutical companies and research institutions improve R&D efficiency, accelerate the market launch of drugs and medical devices, and benefit countless patients.



